Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...

Novo Nordisk’s efforts to ward off competition against its aging diabetes blockbuster Victoza have been quietly simmering in the background. In a citizen petition posted by the FDA this week ...

Fintel reports that on January 8, 2025, UBS upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Sell to Buy. Analyst Price Forecast Suggests 61.15% Upside As of December 23, 2024, the average ...

Basal insulin therapy, currently administered either once or twice daily, is a well-established therapy for diabetes, providing a background ... as daily dosing with Novo Nordisk's Tresiba ...

Alzheimer's disease Therapeutics Market. LAS VEGAS, NV, UNITED STATES, January 23, 2025 /EINPresswire / -- DelveInsight's“Acute Respiratory Distress Synd ...

Gov. Wes Moore enters the reelection cycle with a solid head start. His top donors include the Exelon CEO, Jerry Seinfeld’s ...

The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

But Lilly and Novo Nordisk continue to welcome that challenge ... For instance, patients may already be on other background drugs being administered as a standard of care.

Even without this historical background, Trump’s latest bid is less irrational ... will get it – even if that means ...

When Donald Trump first offered to buy Greenland in 2019, he was widely ridiculed and nothing much came of it, apart from a ...

Trump would have been convicted Democrats to grill Cabinet picks What Senate races to watch in 2026 U.S. officials hopeful ...